Company news
Fulgent Genetics, Inc. news in 2020
Fulgent Genetics, Inc.'s news releases, calls and decks from 2020, newest first.
Fulgent Genetics Extends Partnership with New York City Test and Trace for COVID-19 Testing, Awarded Contract for 2021 School Year
December 28, 2020
PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities
December 16, 2020
Fulgent Genetics to Participate in the Piper Sandler 32nd Annual Healthcare Conference
November 23, 2020
Fulgent Genetics Announces Increase to Full Year 2020 Guidance to $300 million
November 22, 2020
Fulgent Genetics to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference
November 9, 2020
Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million
November 8, 2020
Fulgent Genetics to Announce Third Quarter 2020 Financial Results on Monday November 9, 2020
October 25, 2020
Fulgent Genetics Announces Partnership with Ohio Department of Rehabilitation and Correction for COVID-19 Testing
September 29, 2020
Fulgent Genetics Set to Join S&P SmallCap 600
September 20, 2020
Fulgent Genetics to Provide COVID-19 Testing Solutions for the State of Utah
September 14, 2020
Fulgent Genetics, Miami-Dade County Partner on COVID-19 testing
September 8, 2020
Fulgent Genetics to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference
September 3, 2020
Fulgent Genetics Adds Influenza A and Influenza B to all COVID-19 Tests
September 2, 2020
Fulgent Genetics, New York City Health and Hospitals Partner on Large-Scale Back-to-School COVID-19 Testing
September 1, 2020
Fulgent Genetics Announces Expansion into Houston, TX
August 16, 2020
Fulgent Genetics Reports Record Second Quarter 2020 Financial Results
August 3, 2020
Fulgent Genetics to Announce Second Quarter 2020 Financial Results on Tuesday August 4, 2020
July 13, 2020
Fulgent Genetics Announces FDA Authorization and Launch of At-Home Testing Service for COVID-19
June 15, 2020
Fulgent Genetics Receives Emergency Use Authorization from the FDA for its RT-PCR Test for Detection of SARS-CoV-2, the Virus that Causes COVID-19
May 17, 2020
Fulgent Genetics Reports First Quarter 2020 Financial Results
May 3, 2020
Fulgent Genetics to Announce First Quarter 2020 Financial Results on Monday May 4, 2020
April 8, 2020
Fulgent Genetics Provides Update on Testing for COVID-19
April 8, 2020
Fulgent Genetics Announces Launch of Next Generation Sequencing (NGS) Test to Detect Coronavirus Disease (COVID-19)
March 16, 2020
Fulgent Genetics Reports Fourth Quarter and Full Year 2019 Financial Results
March 9, 2020
Fulgent Genetics Announces Promotion of Brandon Perthuis to Chief Commercial Officer
March 9, 2020
Fulgent Genetics to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday March 10, 2020
February 19, 2020